Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Berg

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Oncotarget|May 8, 2018
Elevated seminal plasma estradiol and epigenetic inactivation of <i>ESR1</i> and <i>ESR2</i> is associated with CP/CPPSNils Nesheim, Stuart Ellem, Temuujin Dansranjavin, et al.
World Journal of Urology|July 22, 2024
The impact of preoperative 5-alpha reductase inhibitors on functional outcomes and health-related quality of life following radical prostatectomy - A propensity score matched longitudinal studyThilo Westhofen, Kerstin Frank, Alexander Buchner, et al.
International Journal of Impotence Research|May 22, 2024
Trends and outcomes of hospitalized patients with priapism in Germany: results from the GRAND studyNikolaos Pyrgidis, Gerald B Schulz, Michael Chaloupka, et al.
Cancers|June 27, 2024
Toxicity-Induced Discontinuation of Immune Checkpoint Inhibitors in Metastatic Urothelial Cancer: 6-Year Experience from a Specialized Uro-Oncology CenterSeverin Rodler, Can Aydogdu, Isabel Brinkmann, et al.
EJNMMI Research|June 23, 2026
Outcome after primary directed radiotherapy in predominantly PSMA-PET/CT-staged patients with metastatic prostate cancerChristian Trapp, Sarah Frederike Brose, Michael Keilholz, et al.
International Journal of Impotence Research|November 19, 2023
Perioperative outcomes of penile prosthesis implantation in Germany: results from the GRAND studyNikolaos Pyrgidis, Gerald B Schulz, Michael Chaloupka, et al.
BJU International|December 7, 2023
Added value of randomised biopsy to multiparametric magnetic resonance imaging-targeted biopsy of the prostate in a contemporary cohortMichael Chaloupka, Nikolaos Pyrgidis, Benedikt Ebner, et al.
Diagnostics (Basel, Switzerland)|August 26, 2023
The Impact of Prostate Volume on the Prostate Imaging and Reporting Data System (PI-RADS) in a Real-World SettingYannic Volz, Maria Apfelbeck, Nikolaos Pyrgidis, et al.
World Journal of Urology|October 20, 2024
Optimizing risk stratification for intermediate-risk prostate cancer - the prognostic value of baseline health-related quality of lifeThilo Westhofen, Alexander Buchner, Simon Lennartz, et al.
Clinical Hemorheology and Microcirculation|September 18, 2023
mpMRI-targeted biopsy of the prostate in men ≥ 75 years. 7-year report from a high-volume referral centerMichael Chaloupka, Nikolaos Pyrgidis, Benedikt Ebner, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Oncotarget|May 8, 2018
Elevated seminal plasma estradiol and epigenetic inactivation of <i>ESR1</i> and <i>ESR2</i> is associated with CP/CPPSNils Nesheim, Stuart Ellem, Temuujin Dansranjavin, et al.
World Journal of Urology|July 22, 2024
The impact of preoperative 5-alpha reductase inhibitors on functional outcomes and health-related quality of life following radical prostatectomy - A propensity score matched longitudinal studyThilo Westhofen, Kerstin Frank, Alexander Buchner, et al.
International Journal of Impotence Research|May 22, 2024
Trends and outcomes of hospitalized patients with priapism in Germany: results from the GRAND studyNikolaos Pyrgidis, Gerald B Schulz, Michael Chaloupka, et al.
Cancers|June 27, 2024
Toxicity-Induced Discontinuation of Immune Checkpoint Inhibitors in Metastatic Urothelial Cancer: 6-Year Experience from a Specialized Uro-Oncology CenterSeverin Rodler, Can Aydogdu, Isabel Brinkmann, et al.
EJNMMI Research|June 23, 2026
Outcome after primary directed radiotherapy in predominantly PSMA-PET/CT-staged patients with metastatic prostate cancerChristian Trapp, Sarah Frederike Brose, Michael Keilholz, et al.
International Journal of Impotence Research|November 19, 2023
Perioperative outcomes of penile prosthesis implantation in Germany: results from the GRAND studyNikolaos Pyrgidis, Gerald B Schulz, Michael Chaloupka, et al.
BJU International|December 7, 2023
Added value of randomised biopsy to multiparametric magnetic resonance imaging-targeted biopsy of the prostate in a contemporary cohortMichael Chaloupka, Nikolaos Pyrgidis, Benedikt Ebner, et al.
Diagnostics (Basel, Switzerland)|August 26, 2023
The Impact of Prostate Volume on the Prostate Imaging and Reporting Data System (PI-RADS) in a Real-World SettingYannic Volz, Maria Apfelbeck, Nikolaos Pyrgidis, et al.
World Journal of Urology|October 20, 2024
Optimizing risk stratification for intermediate-risk prostate cancer - the prognostic value of baseline health-related quality of lifeThilo Westhofen, Alexander Buchner, Simon Lennartz, et al.
Clinical Hemorheology and Microcirculation|September 18, 2023
mpMRI-targeted biopsy of the prostate in men ≥ 75 years. 7-year report from a high-volume referral centerMichael Chaloupka, Nikolaos Pyrgidis, Benedikt Ebner, et al.
Pageof 3